Investors
Investors
Bioquell is a UK-headquartered, international technology group with two principal divisions: Bio-decontamination and TRaC. The Bio-decontamination division develops, designs and manufactures specialist surface sterilisation and filtration technology used in the life sciences, healthcare and defence sectors around the world. The TRaC division provides specialist testing, regulatory and compliance services to companies and organisations, principally in the UK.
Bioquell PLC's shares are listed on the London Stock Exchange. Set out in this section of the website is financial and governance information which is intended to be helpful to actual or prospective shareholders. Further information on the equipment and/or services provided by Bioquell's two principal divisions can be found on the following links:
For further information please contact us.
News/announcements
- 18 January 2012 Award of a £1.2 million development contract by General Dynamics as part of the new SV vehicle
- 18 November 2011 Interim Management Statement - 18 November 2011
- 03 October 2011 Bioquell PLC Financial Calendar
- 03 October 2011 Preference Shares Anouncement
- 16 September 2011 Bioquell PLC Interim Report 2011
Bioquell: 
TRaC:
